Ridgefield, CT, October 28, 2021 (GLOBE NEWSWIRE) – Valam Corp. announced plans to form a new company to “foster the adoption of new technologies that improve ENT procedures in the office,” according to a press release. Over the past two years, Valam has developed and secured an extensive product portfolio with assets focused on 4 ENT market segments, each with complete clinical solutions. The formation of the new company is part of the transformation process to become a power in the ENT market.

The new company will be independent with the aim of establishing a new level of patient comfort and surgeon confidence that accelerates the adoption of ENT surgical procedures in the office.

The company expects this planned launch to create growth and enhance value for all stakeholders.

“As part of Valam’s transformation, we are launching our new business to become a leading player in the ENT field and drive value creation,” said Ron Hadani, Executive Chairman of Valam, in the statement. “For Valam, the transaction is an important step in our refocus on developing and commercializing new comprehensive surgical solutions where we have a clear path to leadership and the ability to win. We believe the new company will thrive with a priority capital allocation to pursue strategic growth opportunities in the large and growing office ENT market. This transaction underscores our commitment to ensuring that our priorities are aligned with the best interests of shareholders as we move the business forward to meet the needs of patients and surgeons and advance our mission of fostering the adoption of our new technologies and innovations that improve ENT procedures in the office, resulting in exceptional clinical and economic results. added Hadani.

The company has targeted 1:22 for the launch according to the statement.


Ron Hadani Valam Corp C: 201-961-3003 [email protected]

Copyright 2021 GlobeNewswire, Inc.

About The Author

Related Posts

Leave a Reply

Your email address will not be published.